Cevian Capital disclosed a stake exceeding 14% in Smith & Nephew in a late-July filing, crossing the threshold that grants meaningful governance leverage in the $11 billion London-listed medical devices company. The Swedish activist, managing roughly $15 billion, now holds sufficient voting power to block special resolutions under UK takeover rules, where 75% approval is required for major corporate actions. Smith & Nephew shares trade at $24.80, down 18% year-to-date, underperforming the MSCI World Health Care Index by 22 percentage points.
Cevian has been circling Smith & Nephew since at least 2022, when the firm first disclosed a position below 5%. The steady accumulation—from single digits to double digits, now past the blocking threshold—follows a pattern Cevian used at Bilfinger and ThyssenKrupp: build quietly, cross governance tripwires, then present a restructuring blueprint. Smith & Nephew operates three divisions: orthopedics, sports medicine, and advanced wound care. The orthopedics unit, which generates $2.1 billion in annual revenue, has lagged Stryker and Zimmer Biomet in hip and knee implant market share, losing 140 basis points since 2020 according to Jefferies research. The wound care division, historically the cash engine, saw operating margins compress to 16.2% in the most recent quarter, down from 19.4% two years prior.
The 14% threshold matters because it positions Cevian to veto any proposed merger or sale without board consent. Smith & Nephew has been mentioned in takeover speculation involving Stryker and Johnson & Johnson's MedTech spinout, but no formal process has emerged. Cevian's typical playbook does not involve selling the company; the firm prefers operational overhauls that unlock value through margin expansion and portfolio pruning. At Ericsson, where Cevian held 6%, the activist pressed for network equipment simplification and cost cuts that lifted EBIT margins by 800 basis points over four years. At Volvo, a 9% stake led to truck-platform consolidation and the spin-off of non-core construction equipment. Smith & Nephew's wound care division, with its lower growth and declining margins, fits the profile of an asset Cevian might push to separate or sell.
Allocators should watch for two developments in the next 90 days: first, whether Cevian formally requests board representation, which would signal a shift from passive accumulation to active engagement; second, whether Smith & Nephew announces any changes to its October capital markets day agenda, where management is expected to present a three-year plan. If Cevian's influence is already shaping that presentation, expect language around portfolio review and margin targets. The UK Takeover Code requires any entity crossing 30% to make a full bid, so Cevian has room to add another 15 percentage points without triggering a mandatory offer. The firm has not yet filed a Schedule 13D in the US, where Smith & Nephew ADRs trade on the NYSE, which suggests the position is held entirely through London.
Smith & Nephew's enterprise value sits at $13.2 billion, trading at 12.4x forward EBITDA, a 20% discount to the med-tech peer group average of 15.5x. Cevian's entry cost is estimated between $22 and $26 per share based on accumulated volume data from FactSet. The activist now controls enough stock to force conversation without forcing control.
The takeaway
Cevian's 14% stake in Smith & Nephew crosses UK blocking threshold; expect operational overhaul, not sale, within six months.
Want the 60-second program for your specific event?
Enter your event and email — we build it and send the branded proposal before lunch. No obligation.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori heritage press through approved vendors · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.